We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




New Chip Detects Intracardiac Ventricular Fibrillation

By HospiMedica International staff writers
Posted on 07 May 2013
A new low-power intracardiac signal-processing chip for cardiac resynchronization therapy (CRT) helps detect ventricular fibrillation.

Developed by researcher at IMEC (Leuven, Belgium), the new chip delivers innovative signal processing functionalities and consumes only 20 µW when all channels are active, enabling the miniaturization of implantable devices. More...
The integrated circuit features three power-efficient, intracardiac electrocardiogram (ECG) signal readout channels; each of the three channels is equipped with a precision ECG signal readout circuit with very low-power consumption and an analog signal processor to extract the features of signal for detection of ventricular fibrillation.

The feature extractor achieves only 2 ms latency to facilitate responsive CRT. The chip also includes features that improve the functionality of CRT devices, such as a low-power accelerometer readout channel that enables rate adaptive pacing, and a 16-level digital sinusoidal current generator to handle intra-thoracic fluid analysis. The generator provides 82 db wide dynamic range bioimpedance measurement, in the range of 0.1–4.4 kΩ with 35 mΩ resolution, achieving over 97% accuracy. The chip was presented at the International Solid State Circuits Conference (ISSCC), held during February 2013 in San Francisco (CA, USA).

Robust and accurate heart rate monitoring of the right and left ventricles and right atrium is essential for CRT implantable devices. Accurate motion sensor and thoracic impedance measurements to analyze intra-thoracic fluid are critical for improving clinical research and analysis of the intracardiac rhythm. Moreover, extreme low-power consumption is required to further reduce the size of cardiac implants and improve the patient's quality of life.

Related Links:

IMEC




Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Emergency Ventilator
Shangrila935
LED Surgical Lamp
ACEMST35/57
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.